← Open Payments lookup

MARY TULLOS: Open Payments

NPI 1639339682 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$867 in 45 payments from 17 companies in 2025. Trend: 2023 $1,110 · 2024 $1,021 · 2025 $867

Food & beverage: $867
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$178
Lilly USA, LLC10$140
Novo Nordisk Inc5$81
Boston Scientific Corporation2$69
Bayer Healthcare Pharmaceuticals Inc.3$56
Otsuka America Pharmaceutical, Inc.2$51
ABBVIE INC.2$48
Electromed, Inc.2$37
Phathom Pharmaceuticals, Inc.2$31
Boehringer Ingelheim Pharmaceuticals, Inc.2$29

Products named: AIRSUPRA, MOUNJARO, Kerendia, REXULTI, CDS - MCT/CEM Monitoring, Ozempic, SMARTVEST, QULIPTA.

Industry payments across MS — which companies pay providers there.